EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Co-Delivery of Chemotherapy and Anti-Angiogenic Lipid via DPPA-LNPs Potentiates Anti-PD-1 Immunotherapy

Jiabao Tan, Junyue Fang iD, Wanrong Luo, Xiaojiang Chen, Yixia Liang, Ziqi Huang, Shiyu Tan, Meng Ren, Xiaoding Xu iD, Wenyue Zhang iD, Phei Er Saw iD

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s544668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Jiabao Tan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Y…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Epirubicin, Phosphatidic Acids, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsEpirubicinPhosphatidic AcidsCarcinoma, HepatocellularLiver NeoplasmsMammary Neoplasms, ExperimentalTumor MicroenvironmentAngiogenesis InhibitorsAntineoplastic Combined Chemotherapy ProtocolsLiposomesNanoparticlesNanoparticle Drug Delivery SystemAntibiotics, AntineoplasticImmunogenic Cell DeathProgrammed Cell Death 1 ReceptorCell Line, TumorAnimalsMiceHuman Umbilical Vein Endothelial CellsHumansMice, Inbred C57BLMice, Inbred BALB CMaleFemaleDrug SynergismDrug Resistance, Neoplasm

Stichwörter der Autor:innen

DPPAICDPD-1TMEanti-angiogenesisdipalmitoyl phosphatidic acidimmunogenic cell deathprogrammed cell death protein 1tumor microenvironment

Substanzen

Immune Checkpoint InhibitorsEpirubicinAngiogenesis InhibitorsLipid NanoparticlesLiposomesNanoparticle Drug Delivery Systemdipalmitoylphosphatidic acidPhosphatidic AcidsAntibiotics, AntineoplasticProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
  • Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-Sen Memorial Hospital, Foshan, 528200, People's Republic of China.
  • Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
  • Cellular and Molecular Diagnostics Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
  • Department of Ultrasound, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, People's Republic of China.
  • Department of Gastric Surgery, Sun Yat-sen University Cancer Center; Sun Yat-sen University, Guangzhou, 510060, People's Republic of China.

ORCID-Profile: Junyue Fang, Xiaoding Xu, Wenyue Zhang, Phei Er Saw

Zitieren

APA

Tan, J., Fang, J., Luo, W., Chen, X., Liang, Y., Huang, Z., Tan, S., Ren, M., Xu, X., Zhang, W., & Saw, P. E. (2025). Co-Delivery of Chemotherapy and Anti-Angiogenic Lipid via DPPA-LNPs Potentiates Anti-PD-1 Immunotherapy. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s544668

Vancouver

Tan J, Fang J, Luo W, Chen X, Liang Y, Huang Z, et al. Co-Delivery of Chemotherapy and Anti-Angiogenic Lipid via DPPA-LNPs Potentiates Anti-PD-1 Immunotherapy. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s544668

BibTeX
@article{Tan2025,
  author = {Tan, Jiabao and Fang, Junyue and Luo, Wanrong and Chen, Xiaojiang and Liang, Yixia and Huang, Ziqi and Tan, Shiyu and Ren, Meng and Xu, Xiaoding and Zhang, Wenyue and Saw, Phei Er},
  title = {Co-Delivery of Chemotherapy and Anti-Angiogenic Lipid via DPPA-LNPs Potentiates Anti-PD-1 Immunotherapy},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s544668}
}
Kostenlos starten →